Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06996171

Comparative Efficacy of Magnesium Supplement and Melatonin Congener in Young Adults With Primary Insomnia

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
CMH Kharian Medical College · Other Government
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Not accepted

Summary

Sleep is essential for our overall health and well-being, much like food and water. It plays a vital role in numerous bodily functions. Many studies have been conducted to determine the efficacy of melatonin congeners and Mg supplements in patients with insomnia separately. This study aims to compare the efficacy of melatonin and magnesium supplements in young adults with primary insomnia. Most insomnia studies focus on older adults or individuals with comorbidities. Targeting otherwise healthy young adults brings age-specific relevance and novel insight.

Conditions

Interventions

TypeNameDescription
DRUGMagnesium glycinateTab Magnesium glycinate 500mg will be given to one group for treatment of primary insomnia
DRUGMelatoninTab Melatonin 10mg will be given to the other group for treatment of primary insomnia

Timeline

Start date
2025-05-05
Primary completion
2025-08-31
Completion
2025-10-30
First posted
2025-05-30
Last updated
2025-05-30

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT06996171. Inclusion in this directory is not an endorsement.

Comparative Efficacy of Magnesium Supplement and Melatonin Congener in Young Adults With Primary Insomnia (NCT06996171) · Clinical Trials Directory